ALXO
Price
$1.05
Change
-$0.03 (-2.78%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
56.23M
50 days until earnings call
MDGL
Price
$417.43
Change
-$9.62 (-2.25%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
9.52B
43 days until earnings call
Interact to see
Advertisement

ALXO vs MDGL

Header iconALXO vs MDGL Comparison
Open Charts ALXO vs MDGLBanner chart's image
ALX Oncology Holdings
Price$1.05
Change-$0.03 (-2.78%)
Volume$15.56K
Capitalization56.23M
Madrigal Pharmaceuticals
Price$417.43
Change-$9.62 (-2.25%)
Volume$4.55K
Capitalization9.52B
ALXO vs MDGL Comparison Chart in %
Loading...
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALXO vs. MDGL commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALXO is a Hold and MDGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (ALXO: $1.08 vs. MDGL: $427.05)
Brand notoriety: ALXO and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALXO: 18% vs. MDGL: 59%
Market capitalization -- ALXO: $56.23M vs. MDGL: $9.52B
ALXO [@Biotechnology] is valued at $56.23M. MDGL’s [@Biotechnology] market capitalization is $9.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALXO’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • ALXO’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than ALXO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALXO’s TA Score shows that 3 TA indicator(s) are bullish while MDGL’s TA Score has 4 bullish TA indicator(s).

  • ALXO’s TA Score: 3 bullish, 5 bearish.
  • MDGL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than ALXO.

Price Growth

ALXO (@Biotechnology) experienced а -0.92% price change this week, while MDGL (@Biotechnology) price change was -4.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was +6.99%, and the average quarterly price growth was +35.85%.

Reported Earning Dates

ALXO is expected to report earnings on Nov 06, 2025.

MDGL is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($9.52B) has a higher market cap than ALXO($56.2M). MDGL YTD gains are higher at: 38.396 vs. ALXO (-35.329). ALXO has higher annual earnings (EBITDA): -114.05M vs. MDGL (-266.74M). MDGL has more cash in the bank: 797M vs. ALXO (79.3M). ALXO has less debt than MDGL: ALXO (10M) vs MDGL (124M). MDGL has higher revenues than ALXO: MDGL (516M) vs ALXO (0).
ALXOMDGLALXO / MDGL
Capitalization56.2M9.52B1%
EBITDA-114.05M-266.74M43%
Gain YTD-35.32938.396-92%
P/E RatioN/AN/A-
Revenue0516M-
Total Cash79.3M797M10%
Total Debt10M124M8%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALXOMDGL
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGABX78.400.05
+0.06%
American Funds Growth Fund of Amer R2
NOLCX32.88N/A
N/A
Northern Large Cap Core
MXKJX8.65N/A
N/A
Empower Mid Cap Value Instl
DIEMX45.49N/A
N/A
Driehaus Emerging Markets Growth Instl
CVAIX25.28N/A
N/A
Calamos Select Fund I

ALXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
+2.86%
MDGL - ALXO
56%
Loosely correlated
+0.34%
AXON - ALXO
45%
Loosely correlated
-1.33%
AMRN - ALXO
43%
Loosely correlated
N/A
ALNY - ALXO
39%
Loosely correlated
+0.02%
NUVB - ALXO
37%
Loosely correlated
+3.81%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with ALXO. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then ALXO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+0.34%
ALXO - MDGL
56%
Loosely correlated
+2.86%
NAGE - MDGL
45%
Loosely correlated
-1.96%
IPHA - MDGL
44%
Loosely correlated
+0.19%
RNAC - MDGL
43%
Loosely correlated
-1.94%
GHRS - MDGL
43%
Loosely correlated
-3.66%
More